Educational research platform

Before you begin

Welcome to Peptide Relay

Explore source-linked research, practical tools, and Community Intelligence with evidence, interpretation, and personal experience kept clearly separated.

Please confirm
Choose how you enter RelayYou can change your mind and create a workspace later.

No account is required for the Research Library, Learn, Compare, Stack Explorer, Community, or Tools. A free workspace is only required for private features such as My Relay, Protocol Tracker, saved work, following compounds, and managing Community Experiences.

Peptide Relay status

Public Alpha

v0.9.0

Building Relay with the community.

Relay is now feature-complete and has entered its first Public Alpha.

From this point forward, improvements are driven by real-world usage, community feedback, analytics, and research rather than internal feature planning.

Thank you for helping shape Relay.

What's NewWhat shipped in the current release
v0.9.0 — Public AlphaJuly 2026

Research Library

Thirty-five source-traceable compound and blend profiles with plain-English summaries, detailed science, evidence context, timelines, and references.

Learn

Peptide 101 and seven cornerstone guides for reading studies, mechanisms, evidence strength, personal experiences, and research uncertainty.

Compare

Side-by-side research context with shared, different, and unknown states—without inventing head-to-head conclusions.

Stack Explorer

Multi-compound pathway and evidence analysis with exact-combination limits and unanswered questions kept visible.

Community Experiences

Anonymous structured Experience Reports, separate story consent, verified follow-ups, moderation, and privacy-thresholded Community Intelligence.

Protocol Tracker

Private schedules, administrations, reflections, measurements, inventory, imports, lifecycle controls, and reconstitution support.

Reconstitution Hub

Single-compound and blend calculations, visual syringe and vial interpretation, reference marks, and private saved workspaces.

Relay-wide Search

One alias-aware search experience across public research and signed-in workspace destinations.

Mobile Optimization

Reliable touch selection, tighter information density, responsive tables and tabs, and mobile-first workflow refinement.

Motion System

One restrained motion language that explains state changes and respects reduced-motion preferences.

Platform Improvements

Database contract auditing, private-route indexing boundaries, public-route smoke tests, clearer recovery messages, and stronger protection against false-success writes.

RoadmapDirection without promised timelines

Roadmap items describe current direction. Public Alpha evidence may change their order or scope.

Now
  • Community growth
  • Bug fixes
  • UX improvements
  • Content expansion
Next
  • Relay+ features
  • Additional research tools
  • Expanded compound library
Future
  • Relay AI
  • Native iPhone app (planned)
  • Native Android app (planned)
Known IssuesMeaningful issues users may encounter
No known critical issues at this time.

Newly confirmed issues will appear here when they meaningfully affect the public experience.

FeedbackHelp improve the next release

Found a bug?Have a suggestion?

Submit feedback to help improve Relay
Version HistoryPublic releases and milestones
v0.9.0

Public Alpha

The first feature-complete public release candidate for Peptide Relay.

Released July 2026

Last updated July 2026 · Updated with every public release.

Peptide 101 · Guide 5 of 6

What does a COA tell us—and not tell us?

Read a laboratory report as a set of separate tests on a specific submitted sample.

The simple answer

A certificate of analysis, or COA, reports tests performed on a specific submitted sample. A useful report identifies the sample or lot, methods, acceptance limits when applicable, numerical results, dates, and the laboratory responsible.

Identity, purity, quantity, sterility, and endotoxin are separate questions. A result for one does not answer the others, and one tested sample does not automatically prove that every vial or every product with the same label is equivalent.

5 min read Reviewed July 28, 2026 7 sources

Read the report before reading the headline result

Start with the laboratory name, report identifier, client, sample description, lot or batch information, received and testing dates, method, and result. These details connect the number to a sample and a procedure.

A percentage or pass result without a clear sample identity and method is difficult to interpret. The laboratory can only report what it received and tested.

Each test answers one question

Identity asks whether the tested material is consistent with the expected compound under the method used. Purity estimates how much of the method’s measured signal is attributed to the target rather than detected related components or impurities.

Quantity, assay, or net-content testing estimates how much target material is present in the tested sample. A high purity percentage does not establish the total amount. For example, a small amount of highly pure material can still be less material than the label claims.

Sterility and endotoxin are not the same

A sterility test looks for viable microorganisms under defined test conditions. A bacterial endotoxin test looks for endotoxins associated with certain bacteria.

Endotoxins can remain even when living bacteria are absent, and FDA notes that most sterilization methods do not inactivate endotoxins. A sterility result therefore cannot stand in for endotoxin testing, and an endotoxin result cannot stand in for sterility testing.

The sample-to-batch connection matters

A laboratory result applies directly to the sample tested. Extending it to a batch requires confidence that the sample was correctly identified, collected, stored, and representative of that batch.

Representative sampling and chain of custody do not make a result perfect, but they help answer whether the tested material reasonably corresponds to the product being discussed.

Laboratory competence has a scope

ISO/IEC 17025 is a standard laboratories can use to demonstrate technical competence and the ability to generate valid results. Accreditation is meaningful, but it should be checked for the relevant laboratory, method, and scope—not treated as a universal badge covering every test.

Method suitability, controls, detection limits, reference materials, and uncertainty can all affect what a result supports.

Key terms

Identity
Whether the sample’s measured characteristics are consistent with the expected compound.
Purity
The target’s share of what a specific analytical method detects; its meaning depends on the method.
Quantity / assay
An estimate of how much target material is present in the tested sample.
Sterility test
A test for viable microorganisms under defined test conditions.
Endotoxin test
A separate test that detects or quantifies bacterial endotoxins.
Specification
A test, its method, and the acceptance criterion the result is compared with.

Five questions—not one quality score

IdentityIs it consistent with the target?
PurityWhat share of the measured signal is target?
QuantityHow much target was measured?
SterilityWere viable microorganisms detected?
EndotoxinWere bacterial endotoxins detected?
Passing one measurement does not imply that the others were tested or passed.

What this can—and cannot—tell us

What it can tell us

  • Which tests were performed on the submitted sample and what results were reported.
  • Whether the results met stated acceptance criteria, when criteria are provided.
  • Which laboratory, method, dates, and identifiers support the report.

What it cannot establish alone

  • Anything about a test that was not performed.
  • That every unit in a batch—or a different batch—is identical to the tested sample.
  • That a product is safe, effective, approved, correctly stored, or appropriate for use.
  • That a purity percentage equals the labeled quantity.
Go deeperOptional · about 1 minute

Why purity and quantity can disagree

Chromatographic purity is often expressed as a percentage of detected peak area. That can be useful for comparing the target signal with other detected signals under the method.

It is not automatically a measurement of total mass. Water, salts, residual solvents, or components not detected in the same way may not be represented by that percentage. Quantity needs an appropriate assay or content method.

What a strong COA usually makes visible

FDA’s discussion of active-ingredient COAs includes the material name, grade, batch or lot number, release date, each required test, acceptance limits, and numerical results. A report should also make the issuing laboratory and authorization clear.

More fields do not guarantee truth, but missing identifiers and methods make independent interpretation and verification harder.

The takeaway

If you only remember one thing from this guide:

A COA describes the tests performed on one submitted sample. It is not a universal guarantee about every quality question or every product with the same label.

Sources and support7 sources
  1. Lists core COA fields including material, batch or lot, tests, acceptance limits, and numerical results.

  2. Separates identity, purity, strength, sterility, pyrogenicity, endotoxin, and other quality tests.

  3. Describes sterility testing under aseptic test conditions.

  4. Bacterial Endotoxins/Pyrogens U.S. Food and Drug Administration

    Explains bacterial endotoxin testing and its distinct purpose.

  5. States that most sterilization methods do not inactivate endotoxins and describes test, method, and acceptance criteria.

  6. ISO/IEC 17025 — Testing and calibration laboratories International Organization for Standardization

    Explains the standard’s role in demonstrating laboratory competence and valid results.

  7. 21 CFR 211.84 — Representative sampling and testing Electronic Code of Federal Regulations

    Supports the importance of representative samples and lot-specific testing.